Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Clinical Stage IV Cutaneous Melanoma AJCC v8 · Metastatic Malignant Neoplasm in the Brain · Metastatic Melanoma · Pathologic Stage IV Cutaneous Melanoma AJCC v8
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Principal Investigator (Kari L. Kendra, MD)
Study leads
Kari L Kendra, MD
Principal Investigator
Ohio State University Comprehensive Cancer Center